Cargando…
Estimating the proportion of vaccine-induced hospitalized dengue cases among Dengvaxia vaccinees in the Philippines
Background: Dengvaxia was used in the Philippines to vaccinate 9-10-year-old school children, living in areas highly endemic for dengue. After about 830,000 had received at least 1 of 3 recommended doses, risks of enhanced disease in dengue-naïve vaccinees were reported. Methods: We used Phase 3 tri...
Autores principales: | Flasche, Stefan, Wilder-Smith, Annelies, Hombach, Joachim, Smith, Peter G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880258/ https://www.ncbi.nlm.nih.gov/pubmed/31815190 http://dx.doi.org/10.12688/wellcomeopenres.15507.1 |
Ejemplares similares
-
Dengvaxia: the world’s first vaccine for prevention of secondary dengue
por: Tully, Danielle, et al.
Publicado: (2021) -
Identification of prior dengue-naïve Dengvaxia recipients with an increased risk for symptomatic dengue during fever surveillance in the Philippines
por: Dai, Yu-Ching, et al.
Publicado: (2023) -
Dengvaxia controversy: impact on vaccine hesitancy
por: Fatima, Khunsha, et al.
Publicado: (2018) -
Does structurally-mature dengue virion matter in vaccine preparation in post-Dengvaxia era?
por: Galula, Jedhan Ucat, et al.
Publicado: (2019) -
Consumer Willingness to Pay for Dengue Vaccine (CYD-TDV, Dengvaxia(®)) in Brazil; Implications for Future Pricing Considerations
por: Godói, Isabella P., et al.
Publicado: (2017)